Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1365937-12-7

Post Buying Request

1365937-12-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1365937-12-7 Usage

General Description

(3S)-1-(Quinazolin-4-yl)pyrrolidin-3-amine is a chemical compound with the molecular formula C14H16N4. It is a pyrrolidine derivative with a quinazoline group attached to the nitrogen atom. (3S)-1-(Quinazolin-4-yl)pyrrolidin-3-amine has potential pharmaceutical applications, particularly in the development of new drugs for the treatment of various diseases. Its structure and properties make it an interesting candidate for further research and development, particularly in the fields of medicinal chemistry and drug discovery. The compound's unique structure and potential biological activities make it an important target for future studies in the field of drug development.

Check Digit Verification of cas no

The CAS Registry Mumber 1365937-12-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,5,9,3 and 7 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1365937-12:
(9*1)+(8*3)+(7*6)+(6*5)+(5*9)+(4*3)+(3*7)+(2*1)+(1*2)=187
187 % 10 = 7
So 1365937-12-7 is a valid CAS Registry Number.

1365937-12-7Downstream Products

1365937-12-7Relevant articles and documents

AMINOQUINOLINE AND AMINOQUINAZOLINE KINASE MODULATORS

-

Page/Page column 37, (2010/11/25)

The invention is directed to aminoquinoline and aminoquinazoline compounds of Formula I: where R1, R2, R3, B, Z, Q, p, q and X are as defined herein, the use of such compounds as protein tyrosine kinase modulators, particularly inhibitors of FLT3 and/or TrkB, the use of such compounds to reduce or inhibit kinase activity of FLT3 and/or TrkB in a cell or a subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to FLT3 and/or TrkB. The present invention is further directed to pharmaceutical compositions comprising the compounds of the present invention and to methods for treating conditions such as cancers and other cell proliferative disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1365937-12-7